Hunan Hansen Pharmaceutical Co., Ltd. (SHE:002412)

SHE:002412 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Equivalents	72.04	249.65	128.02	51.13	145.41	90.31
Trading Asset Securities	370.03	333.8	244.12	203.87	135.82	49.24
Cash & Short-Term Investments	442.07	583.45	372.14	255	281.23	139.55
Cash Growth	-3.15%	56.78%	45.94%	-9.33%	101.52%	34.75%
Accounts Receivable	408.54	426.42	425.03	352.52	320.57	272.88
Other Receivables	6.82	0.94	0.88	0.63	11.96	1.86
Receivables	415.36	437.17	442	359.99	332.53	274.74
Inventory	220.94	208.44	222.88	231.12	246.62	103.37
Prepaid Expenses	-	9.13	6.9	3.8	-	1.23
Other Current Assets	93.96	83.62	79.25	46.16	5.03	16.51
Total Current Assets	1,172	1,322	1,123	896.07	865.4	535.41
Property, Plant & Equipment	443.76	455.72	489.16	515.61	439.45	470.75
Long-Term Investments	747.94	836.44	855.75	841.81	781.35	707.95
Goodwill	14.73	14.73	14.79	14.79	14.79	53.03
Other Intangible Assets	28.61	28.66	29.3	29.54	33.72	42.58
Long-Term Deferred Tax Assets	2.04	2.24	2.42	2.5	2.04	2.11
Long-Term Deferred Charges	14.52	14.94	14.41	15.13	15.71	16.42
Other Long-Term Assets	19.19	18.52	18.23	21.04	138.47	283.03
Total Assets	2,443	2,693	2,547	2,336	2,291	2,111

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Accounts Payable	21.34	34.28	41.62	41.11	43.63	51.44
Accrued Expenses	17.31	49.97	48.31	62.58	66.83	48.31
Short-Term Debt	1	57.5	84.51	95.12	120.15	131.79
Current Income Taxes Payable	10.85	9.04	6.23	11.64	4.61	4.52
Current Unearned Revenue	1.05	0.81	2.72	6.48	7.02	1.71
Other Current Liabilities	27.7	136.72	134.93	138.51	138	113.33
Total Current Liabilities	79.26	288.33	318.32	355.42	380.24	351.11
Long-Term Unearned Revenue	22	23.01	24.54	16.81	15.03	16.22
Long-Term Deferred Tax Liabilities	0.81	0.81	1	1.22	1.54	1.66
Total Liabilities	102.07	312.15	343.85	373.46	396.81	368.99

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Common Stock	503.2	503.2	503.2	503.2	503.2	503.2
Additional Paid-In Capital	234.12	234.12	234.12	234.12	234.12	232.77
Retained Earnings	1,589	1,634	1,436	1,215	1,161	993.7
Comprehensive Income & Other	14.38	9.87	30.45	10.34	-4.5	12.63
Total Common Equity	2,341	2,381	2,203	1,963	1,894	1,742
Shareholders' Equity	2,341	2,381	2,203	1,963	1,894	1,742
Total Liabilities & Equity	2,443	2,693	2,547	2,336	2,291	2,111

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Total Debt	1	57.5	84.51	95.12	120.15	131.79
Net Cash (Debt)	441.08	525.95	287.63	159.88	161.08	7.76
Net Cash Growth	13.36%	82.86%	79.90%	-0.74%	1975.89%	-
Net Cash Per Share	0.88	1.05	0.57	0.32	0.32	0.02
Filing Date Shares Outstanding	503.17	503.2	503.2	503.2	503.2	503.2
Total Common Shares Outstanding	503.17	503.2	503.2	503.2	503.2	503.2
Working Capital	1,093	1,033	804.85	540.65	485.17	184.3
Book Value Per Share	4.65	4.73	4.38	3.90	3.76	3.46
Tangible Book Value	2,298	2,338	2,159	1,919	1,846	1,647
Tangible Book Value Per Share	4.57	4.65	4.29	3.81	3.67	3.27
Buildings	-	648.15	647.47	644.48	531.89	533.67
Machinery	-	231.59	228.7	223.66	221.69	218.69
Construction In Progress	-	12.77	10.8	9.08	6.09	5.26

Data Source: S&P Global Market Intelligence Last updated: Aug 24, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 10, 2026

Data Sources Report a data error